Advertisement

Picture Berlin Partner Voices Martin Rahmel TU Berlin GreenChem 650x100px
Document › Details

Abivax S.A.. (9/2/22). "Press Release: Abivax Announces Successful Oversubscribed EUR 49.2M Cross-over Financing with Top-tier US and European Biotech Investors [not for US]". Paris.

Organisations Organisation Abivax S.A. (Euronext Paris: ABVX)
  Group Abivax (Group)
  Organisation 2 TCG Crossover Management (US, TCG X, TCGX)
  Group Column Group LLC, The (TCG)
Products Product investment banking
  Product 2 obefazimod (ABX464)
Index term Index term Abivax–SEVERAL: investment, 202209 issuance of royalty certificates for €2.9m
Persons Person Ehrlich, Hartmut J. (Abivax 201410 CEO before Baxter BioScience 200712 VP Global RnD)
  Person 2 Blondel, Didier (Abivax 201701– CFO before Sanofi Pasteur MSD + Sanofi)
     


   
Record changed: 2023-06-05

Advertisement

Picture Sino Biological Symposium Antibody Engineering Leipzig 650x200px

More documents for Abivax (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Sino Biological Symposium Antibody Engineering Leipzig 650x200px




» top